6014 J . Org. Chem., Vol. 63, No. 17, 1998
Temme et al.
H, t, J ) 7.2 Hz), 1.61-2.15 (5 H, m), 3.42-3.51 (1 H, m), and
3.98-4.11 (4 H, m); 13C NMR (75.5 MHz) δ 170.3, 69.6, 66.5,
60.1, 39.0, 33.3, 27.2, 20.2, 14.2, and 11.8; MS (EI) m/z (rel
intensity) 184 (M+, 1), 155 (9), 139 (20), 111 (100), 81 (28),
and 55 (58). Anal. Calcd for C10H16O3: C, 65.20; H, 8.70.
Found: C, 64.93; H, 8.71.
(1R,5R,6S)-5-Ben zyl-6-ca r beth oxy-2-oxa bicyclo[3.1.0]-
h exa n e (34e) a n d (1R,5R,6R)-5-Ben zyl-6-ca r beth oxy-2-
oxa bicyclo[3.1.0]h exa n e (36). The cyclopropanation reac-
tion of enol ether 29 afforded the bicyclic products 34e (189
mg, 77%) and 36 in (49 mg, 20%) as colorless oils.
2936, 1720, and 1298; 1H NMR (300 MHz) δ 1.31 (3 H, t, J )
7.1 Hz), 1.78-2.12 (4 H, m), 2.87-3.11 (3 H, m), 3.52 (1 H, d,
J ) 10.7 Hz), 4.07-4.15 (2 H, m), 4.24 (2 H, q, J ) 7.1 Hz),
and 7.18-7.29 (5 H, m); 13C NMR (75.5 MHz) δ 171.8, 138.7,
133.6, 129.3, 128.1, 68.1, 64.7, 61.3, 37.9, 31.3, 26.4, 21.0, 19.1,
and 14.2; MS (EI) m/z (rel intensity) 260 (M+, 7), 231 (3), 185
(13), 115 (10), 91 (100), and 65 (35). Anal. Calcd for
C16H20O3: C, 73.84; H, 7.69. Found: C, 73.85; H, 7.64.
Det er m in a t ion of t h e E n a n t iom er ic E xcess via Al-
coh ol Der iva tives. (1R*,6R*,7R*)-1-Ben zyl-7-(h yd r oxy-
m eth yl)-2-oxa bicyclo[4.1.0]h ep ta n e (39). Ester 34i (260
mg, 1 mmol) in dry ether (5 mL) was added over 5 min to an
ice-cooled suspension of LiAlH4 (76 mg, 2 mmol) in ether (25
mL). After stirring overnight at room temperature, H2O (1
mL) was added. The suspension was filtered, dried over
MgSO4, and concentrated. The residue was purified by using
flash chromatography (pentane/ethyl acetate: 2/1) to afford
39 (180 mg, 82%) as a colorless oil. Rf 0.15 (pentane/ethyl
34e: Rf 0.28 (pentane/ethyl acetate: 95/5); [R]25D ) -73.0 (c
) 1.19, CH2Cl2, >95% ee); IR (neat, cm-1) 1715, 1417, 1178,
and 1100; 1H NMR (300 MHz) δ 1.25 (3 H, t, J ) 7.1 Hz), 1.95-
2.18 (3 H, m), 3.03 (1 H, d, J ) 14.9 Hz), 3.24 (1 H, d, J ) 14.9
Hz), 3.42-3.51 (1 H, m), 3.97-4.04 (1 H, m), 4.12 (2 H, q, J )
7.1 Hz), 4.31 (1 H, d, J ) 1.7 Hz), 7.16-7.31 (5 H, m); 13C
NMR (75.5 MHz) δ 170.5, 139.4, 128.7, 126.1, 69.4, 66.4, 60.3,
38.2, 33.5, 32.7, 27.5, 14.2, and 11.8; MS (EI) m/z (rel intensity)
246 (M+, 4), 173 (40), 155 (100), 127 (44), 115 (23), 91 (76),
and 55 (51). Anal. Calcd for C15H18O3: C, 73.17; H, 7.32.
Found: C, 73.20; H, 7.45.
acetate: 2/1); [R]25 ) +14.8 (c ) 1.00, CH2Cl2, 74% ee); IR
D
(neat, cm-1) 3383, 2929, 1078, and 706; 1H NMR (300 MHz) δ
0.93 (1 H, t, J ) 6.2 Hz), 1.22-1.29 (3 H, m), 1.61-1.78 (1 H,
m), 1.80-1.91 (1 H, m), 2.03 (1 H, s), 2.66-2.77 (2 H, m), 2.92
(1 H, d, J ) 14.6 Hz), 3.37-3.63 (3 H, m), and 7.12-7.29 (5 H,
m); 13C NMR (75.5 MHz) δ 139.1, 129.1, 128.1, 126.1, 64.2,
63.2, 63.1, 39.8, 30.8, 21.7, 21.5, and 19.5; MS (EI) m/z (rel
intensity) 200 (M+ - H2O, 18), 129 (14), 91 (100), 65 (69), and
53 (67). Anal. Calcd for C14H18O2: C, 77.06; H, 8.26. Found:
C, 77.29; H, 8.30.
36: Rf 0.23 (pentane/ethyl acetate: 95/5); [R]25 ) -54.2 (c
D
) 0.50, CH2Cl2, >95% ee); IR (neat, cm-1) 2979, 1716, 1178
1
(film, cm-1); H NMR (300 MHz) δ 1.31 (3 H, t, J ) 7.1 Hz),
1.68 (1 H, d, J ) 7.7 Hz), 2.08-2.21 (1 H, m), 2.50-2.67 (1 H,
m), 2.88-3.07 (2 H, m), 4.09 (1 H, d, J ) 7.7 Hz), 4.16-4.22 (4
H, m), and 7.23-7.35 (5 H, m); 13C NMR (75.5 MHz) δ 169.8,
138.2, 128.9, 128.5, 126.6, 74.2, 68.5, 60.1, 40.5, 37.5, 33.3, 29.9,
and 14.2; MS (EI) m/z (rel intensity) 246 (M+, 3), 173 (35), 155
(100), 127 (41), and 91 (79). Anal. Calcd for C15H18O3: C,
73.17; H, 7.32. Found: C, 73.03; H, 7.36.
(1R,5S,6R)-5-Ben zyl-6-(h yd r oxym eth yl)-2-oxa bicyclo-
[3.1.0]h exa n e (37). Following the procedure described for 39,
ester 34e (300 mg, 1.2 mmol) gave 37 (218 mg, 85%) as a
colorless oil after flash chromatography (pentane/ethyl ac-
etate: 2/1). Rf 0.18 (pentane/ethyl acetate: 2/1); [R]25D ) -10.1
(c ) 1.00, CH2Cl2, 96% ee); IR (neat, cm-1) 3419; 1H NMR (300
MHz) δ 1.62-1.90 (2 H, m), 2.00-2.20 (2 H, m), 3.00-3.07 (2
H, m), 3.56-3.81 (3 H, m), 3.99-4.06 (1 H, m), and 7.26-7.39
(5 H, m); 13C NMR (75.5 MHz) δ 139.8, 128.7, 128.5, 126.2,
67.4, 66.4, 60.4, 35.1, 33.9, 31.8, and 28.2; MS (EI) m/z (rel
intensity) 173 (M+ - CH2OH, 24), 129 (24), 115 (20), 91 (100),
and 65 (54). Anal. Calcd for C13H16O2: C, 76.47; H, 7.84.
Found: C, 76.48; H, 7.99.
(1R,6S,7R)-6-Ben zyl-7-(h yd r oxym eth yl)-2-oxa bicyclo-
[4.1.0]h ep ta n e (38). Following the procedure described for
39, ester 34h (260 mg, 1.0 mmol) gave 38 (183 mg, 84%) as a
colorless oil after flash chromatography (pentane/ethyl ac-
etate: 2/1). Rf 0.09 (pentane/ethyl acetate: 2/1); [R]25D ) +22.2
(c ) 1.00, CH2Cl2, 96% ee); IR (neat, cm-1) 3393, 2933, and
1136; 1H NMR (300 MHz) δ 1.23-1.27 (1 H, m), 1.36-1.47 (3
H, m), 1.69-1.73 (1 H, m), 1.88-1.94 (1 H, m), 2.05-2.31 (2H,
m), 3.16-3.24 (1 H, m), 3.51-3.62 (2 H, m), 3.72-3.85 (2 H,
m), and 7.24-7.38 (5 H, m); 13C NMR (75.5 MHz) δ 139.2,
129.1, 128.4, 126.2, 64.2, 61.9, 61.3, 39.4, 31.0, 25.1, 25.0, and
21.8; MS (EI) m/z (rel intensity) 187 (M+ - CH2OH, 5), 127
(28), 115 (18), 91 (100), and 65 (40). Anal. Calcd for
(1R,6S,7S)-6-E t h yl-7-ca r b et h oxy-2-oxa b icyclo[4.1.0]-
h ep ta n e (34f). Following the general procedure using enol
ether 19 gave cyclopropane 34f (103 mg, 52%) as a colorless
oil. Rf 0.21 (pentane/ethyl acetate: 95/5); [R]25 ) -14.8 (c )
D
1.42, CH2Cl2, >95% ee); IR (neat, cm-1) 1721, 1158, and 1127;
1H NMR (300 MHz) δ 0.86 (3 H, t, J ) 7.3 Hz), 1.24 (3 H, t, J
) 7.2 Hz), 1.45-1.81 (6 H, m), 2.07-2.15 (1 H, m), 3.24-3.32
(1 H, m), 3.56-3.61 (1 H, m), 3.80-3.84 (1 H, m), and 4.10 (2
H, q, J ) 7.3 Hz); 13C NMR (75.5 MHz) δ 171.4, 65.2, 64.2,
60.1, 33.3, 31.1, 25.4, 25.0, 21.9, 14.3, and 10.0; MS (EI) m/z
(rel intensity) 198 (M+, 3), 169 (51), 141 (36), 125 (100), and
95 (67). Anal. Calcd for C11H18O3: C, 66.67; H, 9.10. Found:
C, 66.75; H, 9.27.
(1R,6S,7S)-6-P r op yl-7-ca r beth oxy-2-oxa bicyclo[4.1.0]-
h ep ta n e (34g). Following the general procedure using enol
ether 30 gave cyclopropane 34g (115 mg, 54%) as a colorless
oil. Rf 0.14 (pentane/ethyl acetate: 95/5); [R]25 ) +2.8 (c )
D
0.90, CH2Cl2, >95% ee); IR (neat, cm-1) 1716, 1307, 1180, and
1132; 1H NMR (300 MHz) δ 0.83-1.75 (13 H, m), 1.92 (1 H, d,
J ) 2.9 Hz), 2.92-3.00 (1 H, m), 3.22-3.36 (2 H, m), 3.91-
3.99 (2 H, m) and 4.11 (1 H, d, J ) 2.9 Hz); 13C NMR (75.5
MHz) δ 171.6, 65.5, 64.0, 60.0, 34.7, 32.1, 31.6, 25.7, 22.2, 19.5,
14.3, and 14.2; MS (EI) m/z (rel intensity) 183 (M+-C2H5, 11),
169 (61), 139 (100), 123 (72), 95 (81), 67 (88), and 55(82). Anal.
Calcd for C12H20O3: C, 67.92; H, 9.43. Found: C, 67.71; H,
9.63.
C
14H18O2: C, 77.06; H, 8.26. Found: C, 76.92; H, 8.41.
Syn th esis of (+)-Qu ebr a ch a m in e (7). Deter m in a tion
of th e Absolu te Con figu r a tion of th e Asym m etr ic Cy-
clop r op a n a tion P r od u cts (34c-h ). (3a S,7a R)-3a -Eth yl-
tetr a h yd r ofu r o[2,3-b]p yr a n -2-on e (40). A solution of ester
34f (580 mg, 2.9 mmol) and 10% H2SO4 (11.6 mL) in dioxane
(5.8 mL) was refluxed for 15 h. The dioxane was removed in
vacuo, and the residue was treated with brine (5 mL) and
extracted with ether (4 × 25 mL). The extracts were washed
with brine (5 mL) and saturated aqueous NaHCO3 (5 mL),
dried over MgSO4, and concentrated in vacuo to give 40 (380
mg, 77%) as a colorless oil which was used in the next step
without purification. Rf 0.44 (pentane/ethyl acetate: 3/1);
(1R,6R,7S)-6-Ben zyl-7-ca r beth oxy-2-oxa bicyclo[4.1.0]-
h ep ta n e (34h ). Following the general procedure using enol
ether 31 gave cyclopropane 34h (174 mg, 67%) as a colorless
oil. Rf 0.12 (pentane/ethyl acetate: 95/5); [R]25 ) -31.7 (c )
D
2.50, CH2Cl2, 96% ee); IR (neat, cm-1) 1716 and 1123; 1H NMR
(300 MHz) δ 1.31 (3 H, t, J ) 7.1 Hz), 1.46-1.51 (2 H, m),
1.74-1.85 (1 H, m), 1.93-1.98 (2 H, m), 2.90-3.07 (2 H, m),
3.22-3.31 (1 H, m), 3.60-3.65 (1 H, m), 4.16-4.24 (3 H, m),
and 7.21-7.35 (5 H, m); 13C NMR (75.5 MHz) δ 171.5, 138.8,
129.1, 128.3, 126.2, 64.9, 64.1, 60.4, 37.4, 32.7, 31.2, 25.0, 21.8,
and 14.3; MS (EI) m/z (rel intensity) 260 (M+, 1), 215 (6), 169
(100), 141 (55), 123 (31), and 65 (54). Anal. Calcd for
[R]25 ) -21.7 (c ) 1.00, CH2Cl2); IR (neat, cm-1) 1787, 1190,
D
1165, and 919; 1H NMR (300 MHz) δ 0.90 (3 H, t, J ) 7.6 Hz),
1.44-1.75 (6 H, m), 2.31 (1 H, d, J ) 16.9 Hz), 2.37 (1 H, d, J
) 16.9 Hz), 3.65-3.72 (1 H, m), 3.80-3.86 (1 H, m), and 5.30
(1 H, s); 13C NMR (75.5 MHz) δ 174.0, 105.2, 67.0, 62.1, 40.6,
40.0, 27.3, 27.0, 20.0, and 8.5; MS (EI) m/z (rel intensity) 154
(4), 125 (17), 97 (85), 69 (55), and 55 (100). Anal. Calcd for
C9H14O3: C, 63.53; H, 8.23. Found: C, 63.75; H, 8.18.
C
16H20O3: C, 73.84; H, 7.69. Found: C, 73.94; H, 7.71.
(1R*,6R*,7R*)-1-Ben zyl-7-car beth oxy-2-oxabicyclo[4.1.0]-
h ep ta n e (34i). Following the general procedure using enol
ether 33 gave cyclopropane 34i (117 mg, 45%) as a colorless
oil. Rf 0.20 (pentane/ethyl acetate: 95/5); IR (neat, cm-1) 2981,